CANCELLO-PURE WEDGE
Report
- Report Number
- 3002719998-2010-00003
- Event Type
- Injury
- Date Received
- April 16, 2010
- Date of Event
- March 8, 2010
- Report Date
- March 18, 2010
- Manufacturer
- RTI BIOLOGICS
- Product Code
- MQV
- PMA / PMN Number
- K072327
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TN, US
- Reporter Occupation
- OTHER
Narratives
INVESTIGATION: ACCORDING TO THE MFG RECORDS THE GRAFT WAS MFR TO SPECIFICATION. THE GRAFT UNDERWENT TWO VALIDATED STERILIZATION METHODS; BIOCLEANSE AND POST PACKAGING GAMMA IRRADIATION AT A VALIDATED DOSE TO ACHIEVE A STERILITY ASSURANCE LEVEL (SAL) OF 10-6 PRIOR TO RELEASE. RE-REVIEW OF BIOCOMPATIBILITY VALIDATIONS AND COMPARISON OF CURRENT PROCESSING TECHNIQUES, SAMPLES OF REP MFG EPISODES, FOOT/ANKLE LITERATURE REVIEW AND ADDITIONAL INF VIVO AND IN VITRO TESTING OF VARIOUS BOVINE PRODUCTS WAS CONDUCTED. RESULTS OF INVESTIGATION: MANY FACTORS MAY LEAD TO NON-UNION. EXAMPLES INCLUDE DECREASED BLOOD SUPPLY, WEIGHT, INFECTION, POOR GLYCEMIC CONTROL, NONCOMPLIANCE WITH THERAPY, MEDICATIONS (E.G. STEROIDS), ADJUNCT HARDWARE/IMPLANTS, THE PHYSICAL LOCATION OF THE SURGICAL SITE, OR A PROLONGED INFLAMMATORY RESPONSE. CONCLUSION: GRAFTS ASSOCIATED WITH LOT#: 2-080311 PASSED ALL RTI RELEASE CRITERIA PRIOR TO DISTRIBUTION. DEVICE EVALUATION IN PROCESS. TO DATE, THE RESULTS OF OUR INVESTIGATION HAVE NOT IDENTIFIED AN AGENT OR EVENT INTRINSIC TO GRAFT MATERIAL OR PROCESSING METHODOLOGY THAT WOULD CONTRIBUTE TO THE TYPE OF EXPERIENCE REPORTED IN THIS COMPLAINT. A WRITTEN REQUEST FOR ADDITIONAL INFO HAS BEEN SUBMITTED TO THE PHYSICIAN.
ON (B) (6) 2008, THE PT UNDERWENT A SURGICAL PROCEDURE WHERE A CANCELLO-PURE WEDGE XENOGRAFT WAS IMPLANTED. ON (B) (6) 2010, THE PT UNDERWENT REVISION SURGERY DUE TO NON-UNION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CANCELLO-PURE WEDGE | BOVINE BONE VOID FILLER (MQV) | MQV | RTI BIOLOGICS | 2-080311 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | Required Intervention |